期刊文献+

肺动脉高压2013:分类与治疗的新趋势 被引量:1

下载PDF
导出
摘要 2013年2月,在法国尼斯召开了第五届世界肺高血压论坛。在这次大会上,肺动脉高压(PAH)的临床分类和治疗有诸多变化,现介绍如下。
作者 蒋鑫 荆志成
出处 《浙江医学》 CAS 2013年第19期1711-1714,共4页 Zhejiang Medical Journal
  • 相关文献

参考文献9

  • 1Parcnt F,Bacliir D,Inamo J,et aI.A hemodynamic study of pul-monary hypertension in sickle cell disease[J]. N Erigl J Med, 2011, 365:44-53.
  • 2Mehari A,Cladwin M T,Tian X,el al. Mortality in adults wich sicikle cell discase and pulmonary hypertension[J]. JAMA, 2012, 307 : 1254-1256.
  • 3Mehari A,Alam S,Tian X,el aI.Hernodynamic prediriors of munality in adults with sickle cell discase[J]. Am J Respir Crit Care Med, 2013,187:840-847.
  • 4Sitbon O, Morrell N. Pathways in pulmonary arterial hypeitension: the future is here[J].Eur Respir Rev,2012,21:321-327.
  • 5Ghofrani H A, Hoepel M M, HLdarik M, et al. Riocigual for chronic thromboembolic pulmonaryhypcrtension and pulmonary arterial hypertension:a phase II study[J].Eur Respir J,2010,36:792-799.
  • 6Hoeper M M, Barst R J, Bourge R C, et al. Tmaiinih mesylate as add-on thcrapy for pulnmnary arterial hypertension:results of the randomizerd I MPRES study[J].Circulation,2013,127:1128-1138.
  • 7Tapson V F,Jing Z C,Xu K F,et al.Oral ireprostinil for the treatment of pulmonary arlerial hypertension in patients on background en- dothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (thefreedom-c2 study):a randomized controlled trial[J].Chesi,2013 May 9.[Epub ahead of print].
  • 8Jing Z C,Parikh K,Pulido T,et aI.Efficacy and safcty of oral trepros- tinilmonothcrapy for the treatment of pulmonary arlerial hypenen- sion : a randomized,controlled trial[J]. Circulation, 2013, 127:624- 633.
  • 9Ishikura K,Yamada N,Ito M,et aI.Beneficial acute effects of rho-ki- nase inhibitor in patients with pulrnunary arlerial hypertension[J]. Cire J, 2006,70:174-178.

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部